Our results are in keeping with those provided by the experimental study by Wang F et al, in which the authors reported that lncRNA TUG1 can improve renal fibrosis in diabetic nephropathy by modulating miRNA 21 targeting tissue inhibitor of metalloproteinase 3 (TIMP 3). This evidence concerns the gene TIMP3 and diabetic kidney disease.